1,160
Views
2
CrossRef citations to date
0
Altmetric
EDITORIAL

High LDL cholesterol and statin use were independently associated with lower eight-year mortality in a cohort free from terminal illness, cardiovascular disease, and diabetes at baseline

References

  • Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007;370:1829–39.
  • Langsted A, Freiberg JJ, Tybjaerg-Hansen A, Schnohr P, Jensen GB, Nordestgaard BG. Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: The Copenhagen City Heart Study with 31 years of follow-up. J Intern Med 2011;270:65–75.
  • Korhonen P, Vesalainen R, Aarnio P, Kautiainen H, Järvenpää S, Kantola I. Assessment of cardiovascular risk in primary health care. Scand J Prim Health Care 2012;30:101–6.
  • Graversen L, Christensen B, Borch-Johnsen K, Lauritzen T, Sandbaek A. Lipid-lowering drugs as primary prevention in general practice: Do patients reach guideline goals and continue treatment?ADDITION Denmark. Scand J Prim Health Care 2011;29:216–21.
  • Ravnskov U. Cholesterol lowering trials in coronary heart disease: Frequency of citation and outcome. BMJ 1992;305:15–19.
  • Nissen SE. High-dose statins in acute coronary syndromes: Not just lipid levels. JAMA 2004;292:1365–7.
  • Ferdinand K C. Are cardiovascular benefits in statin lipid effects dependent on baseline lipid levels?. Curr Atheroscler Rep 2011;13:64–72.
  • Bathum L, Depont Christensen R, Engers Pedersen L, Lyngsie Pedersen P, Larsen J, Nexøe J. Association of lipoprotein levels with mortality in subjects aged 50 + without previous diabetes or cardiovascular disease: A population-based register study. Scand J Prim Health Care 2013;31:172–80.
  • Tuikkala P, Hartikainen S, Korhonen MJ, Lavikainen P, Kettunen R, Sulkava R, et al. Serum total cholesterol levels and all-cause mortality in a home-dwelling elderly population: A six-year follow-up. Scand J Prim Health Care 2010; 28:121–7.
  • Petursson H, Sigurdsson JA, Bengtsson C, Nilsen TI, Getz L. Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 study. J Eval Clin Pract 2012;18:159–68.